Altimmune Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Altimmune, Inc. (ALT)

2.93 +0.03 (+1.03%) USD | NASDAQ | May 26, 16:00

2.97 +0.04 (+1.37%) After-Hours: 04:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for ALT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Madrigal Pharmaceuticals, Inc.	Upgrade
Amgen, Inc.	Upgrade
Verastem, Inc.	Upgrade
Karyopharm Therapeutics, Inc.	Upgrade